企業プロフィール
Orphazyme 株価・ニュース・カタリスト
- ティッカー:
- ORPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Denmark and traded in the U
株価変動の要因
ORPH の終値変動に関する情報は現在取得できません。
企業概要
事業概要
Orphazyme was a CNS-focused biotechnology company built around heat-shock protein biology and rare disease neuroscience programs. Its narrative was centered on difficult neurologic conditions where even modest clinical signals could matter, but the company ultimately became a historical small-cap biotech name.
所在地とセクター分類
Orphazyme was based in Denmark and traded in the U.S. as an ADR, giving it a cross-border biotechnology profile. It belonged to the rare-disease and neuroscience development segment rather than commercial pharma.
ビジネスモデルの特徴
The business model was defined by clinical development, regulatory uncertainty, and the challenge of financing a narrow pipeline. Investors historically watched proof-of-concept data and whether the company could translate biology into an approvable asset.
バイオ業界での位置付け
Orphazyme sits in the historical bucket of high-risk CNS biotech names. It is best understood as a cautionary example of how difficult rare-disease neuroscience development can be for a small public company.
今後のカタリスト
- Orphazyme is a legacy / closeout story now, so the catalysts are any remaining resolution update rather than a pipeline event. The market is focused on residual value.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。